Immunocore Holdings (IMCR) Times Interest Earned (2021 - 2026)
Immunocore Holdings (IMCR) posted quarterly Times Interest Earned of $0.11 for Q1 2026, up 114.62% year-on-year from $0.05 in Q1 2025, and up 101.63% on a QoQ basis from -$6.45 in Q4 2025.
Immunocore Holdings (IMCR) Times Interest Earned (2021 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Times Interest Earned for 6 consecutive years, with $0.11 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 114.62% year-over-year to $0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.5 (up 78.43% YoY) and the FY2025 annual result came in at -$0.23, up 70.35% from the prior year.
- Times Interest Earned improved to $0.11 in Q1 2026 per IMCR's latest filing, from -$6.45 in the prior quarter.
- Over the last five years, Times Interest Earned for IMCR reached as high as $3.46 in Q3 2022 and fell as low as -$21.64 in Q4 2023.
- A 5-year average of -$5.82 and a median of -$3.25 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 114.71% — and 2025, when it tumbled 784.88%.
- Year by year, Times Interest Earned stood at -$7.03 in 2022, then sank by 207.93% to -$21.64 in 2023, then surged by 87.23% to -$2.76 in 2024, then tumbled by 133.36% to -$6.45 in 2025, then jumped by 101.63% to $0.11 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.11, -$6.45, and -$2.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | -6.45 |
| Sep 30, 2025 | -2.36 |
| Jun 30, 2025 | -0.20 |
| Mar 31, 2025 | -0.72 |
| Dec 31, 2024 | -2.76 |
| Sep 30, 2024 | -1.98 |
| Jun 30, 2024 | -3.74 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -21.64 |
| Sep 30, 2023 | -10.71 |
| Jun 30, 2023 | -15.49 |
| Mar 31, 2023 | -11.76 |
| Dec 31, 2022 | -7.03 |
| Sep 30, 2022 | 3.46 |
| Jun 30, 2022 | -11.78 |
| Dec 31, 2021 | -28.07 |
| Sep 30, 2021 | -23.50 |